The RCPACAP board

Our board of directors.

Dr Raymond Chan
MBBS MPH PhD FRACP FRCPA FFSc FAICD

Chairman

Dr Chan is head of the Department of Infectious Disease at Royal Prince Alfred Hospital (RPA) and the Microbiology Laboratory at the RPA campus of NSW Health Pathology. A graduate of the University of Sydney, where he received his Master’s degree and PhD, Dr Chan is also a Fellow of the Australian Institute of Company Directors.

His previous roles include Director of the Royal College of Pathologists of Australasia [RCPA] through his role on Council as Councillor for NSW and as Chair of the (then) Board of Education. He recently completed a 20-year period as an examiner in Microbiology for the RCPA.

Dr Chan is a clinical senior lecturer at the Sydney Medical School. He’s a member of the Medicare Participation Review Committee and the Medical Testing Accreditation Advisory committee of NATA, where he is the NATA/RCPA Liaison Officer. He is a member of the Microbiology Discipline Advisory Committee of the RCPA and chairs NSW Health Pathology’s Microbiology Clinical Stream.

Prof Andrew Clouston
MBBS PhD FRCPA FFSc(RCPA)

Board Member

Dr Andrew Clouston graduated in medicine from the University of Queensland and trained in anatomical pathology at the Princess Alexandra Hospital, developing a special interest in gastrointestinal and liver pathology. Since being awarded a PhD for studies into liver allograft immunopathology his research, funded by grants from the NHMRC, NIH and other funding bodies, has included studies on liver fibrosis, fatty liver disease, liver allograft rejection and gastrointestinal cancer.

He is currently the managing partner of Envoi Specialist Pathologists, a private practice in Brisbane specialising in gastrointestinal pathology that also has a strong emphasis on teaching and internationally competitive research. In addition, he is a visiting senior specialist to the Royal Brisbane and Women’s Hospital, Professor of Molecular and Cellular Pathology at the University of Queensland and Clinical Fellow at the Queensland Institute of Medical Research. He has served on a range of national and international committees including the International Consensus Panel for Liver Allograft Pathology, the International Collaboration on Cancer Reporting (ICCR) authoring committee (liver cancer), the National Bowel Cancer Screening Programme, and Australian Cancer Network/NHMRC committees for surveillance protocols in a range of gastrointestinal disorders. He is a frequent presenter at national and international conferences and in 2017 was selected as the RCPA Visiting Lecturer to Overseas.

A/Prof Beverley Rowbotham
MBBS (Hons 1) MD FRACP FRCPA GAICD

Board Member

Bev Rowbotham is a pathologist and non-executive Director with a broad governance experience in healthcare, commerce, government and the non-profit sector. She has a career-long interest in the provision of high-quality healthcare services.  She is Director of Haematology at Sullivan Nicolaides Pathology, past President of the Royal College of Pathologists of Australasia, and has chaired the Australian Medical Association’s policy-making body, Federal Council, since 2014. She has served on four ministerially appointed committees for the Federal Government, including the MBS review, and currently chairs the National Pathology Accreditation Advisory Committee.  She has served on a range of Boards including the Avant Mutual Group, the medical indemnity insurer, Genome. One, a genomics startup, and AEIOU Foundation for children with autism.

Other roles have included President of the Royal College of Pathologists between 2007 and 2009, and President and Chair of the Association for Childhood Language and Related Disorders from 2001 to 2012.

Dr Rowbotham is currently a Federal Councillor for the Australian Medical Association (Pathology Craft Group) and Clinical Lead of Pathology for the National E-Health Transition Authority. She’s the Chair of the National Pathology Accreditation Advisory Council, a member of the Medicare Benefits Schedule Review Taskforce and a director of the Avant Mutual Group, the AEIOU Foundation and Genome One.

Dr Jeanne Tomlinson
MBBS FRCPA FIAC MBA

Board Member

Dr Tomlinson graduated from the University of Western Australia in 1990, receiving its Rolf ten Seldam Gold Medal in Pathology. She obtained fellowship of the Royal College of Pathologists of Australasia in 1997 and the International Academy of Cytology in 2000.

She also attained a master’s degree in Business Administration at the UNSW Business School – Australian Graduate School of Management in 2004. Having worked in both public and private sector laboratories, Dr Tomlinson is currently Medical Director at Laverty Pathology.

Dr Tomlinson has been a director of the Royal College of Pathologists of Australasia through her roles on Council as Honorary Secretary and Treasurer and continues to work as an examiner for the Royal College of Pathologists of Australasia in Anatomical Pathology.

Assoc Prof Tony Landgren
MBBS LLB FRCPA FACLM MRACMA MAICD Barrister & Solicitor, Supreme Court of Victoria

Board Member

Tony Landgren trained in Anatomical and Forensic Pathology in Victoria and was admitted to Fellowship of the Royal College of Pathologists of Australasia in 1990. His subspecialty interests include head and neck pathology, hepatobiliary pathology, lung pathology, renal pathology and biotechnology law.

He’s the National Medical Director and Chief Pathologist at Australian Clinical Labs (formerly Healthscope Pathology) and the Director of Anatomical Pathology at the Royal Melbourne Hospital.

Tony has also been admitted as a Barrister and Solicitor of the Supreme Court of Victoria and is an Associate Professor of Pathology at the University of Melbourne.

Through his role as Chair of the Board of Education and Assessment he’s a Director of the Royal College of Pathologists of Australasia, with responsibility for training all pathology disciplines, the conduct of examinations, assessment of overseas-trained specialists and laboratory accreditation for training.

Tony has been a Board member of the National Association of Testing Authorities since 2016.